Your browser doesn't support javascript.
loading
Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board.
Loeb, Stacy; Cheng, Heather H; Paller, Channing J; Weg, Emily; Johnson, Jennifer; Gross, Laura; Keith, Scott W; Russo, Jessica; Hathaway, Feighanne; Rivera, Adrian; Giri, Veda N.
Affiliation
  • Loeb S; Department of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA. stacyloeb@gmail.com.
  • Cheng HH; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Paller CJ; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MA, USA.
  • Weg E; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Johnson J; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Gross L; Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Keith SW; Division of Biostatistics and Bioinformatics, Sidney Kimmel Medical Colllege, Thomas Jefferson University, Philadelphia, PA, USA.
  • Russo J; MD Anderson Cancer Center at Cooper University Health Care, Camden, NJ, USA.
  • Hathaway F; Hematology/Oncology, Biological Sciences Division, University of Chicago, Chicago, IL, USA.
  • Rivera A; Department of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA.
  • Giri VN; Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
Prostate Cancer Prostatic Dis ; 2024 Jan 03.
Article in En | MEDLINE | ID: mdl-38172199
ABSTRACT

BACKGROUND:

Germline testing is important in prostate cancer and evaluation can be complex.

METHODS:

We instituted a monthly multi-disciplinary virtual genetics tumor board (7/2021-3/2022). Participants and panelists were surveyed on usefulness and acceptability.

RESULTS:

101 participants attended a session, and 77 follow-up surveys were completed. Over 90% participants and 100% panelists endorsed usefulness of the case discussions and usability of the technology. The majority felt it provided new information they will use.

CONCLUSIONS:

A multidisciplinary genetics board was successfully developed to address complexity in prostate cancer genetics. The virtual platform may enhance dissemination of expertise where there are regional gaps.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom